iSpecimen Inc. Files Definitive Proxy Statement for 2024 Annual Meeting

TL;DR

iSpecimen (ISPC) proxy filed for July 19th meeting - vote on directors & governance.

AI Summary

iSpecimen Inc. filed its definitive proxy statement (DEF 14A) on June 10, 2024, for its annual meeting of stockholders scheduled for July 19, 2024. The filing outlines the agenda for the meeting, which includes the election of directors and other corporate governance matters. The company is based in Lexington, MA, and operates in the commercial physical & biological research sector.

Why It Matters

This filing provides shareholders with crucial information regarding the company's leadership, governance, and proposals to be voted on at the upcoming annual meeting, impacting their investment decisions.

Risk Assessment

Risk Level: medium — Proxy statements can reveal changes in leadership, strategic direction, or shareholder proposals that may impact the company's future performance and stock price.

Key Numbers

• 20240610 — Filing Date (Date the DEF 14A was filed with the SEC.)
• 20240719 — Meeting Date (Date of the shareholder meeting for which the proxy is being filed.)

Key Players & Entities

• iSpecimen Inc. (company) — Registrant
• June 10, 2024 (date) — Filing Date
• July 19, 2024 (date) — Annual Meeting Date
• Lexington, MA (location) — Company Headquarters

FAQ

From the Filing

0001104659-24-069891.txt : 20240610 0001104659-24-069891.hdr.sgml : 20240610 20240610090011 ACCESSION NUMBER: 0001104659-24-069891 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20240719 FILED AS OF DATE: 20240610 DATE AS OF CHANGE: 20240610 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 241031563 BUSINESS ADDRESS: STREET 1: 450 BEDFORD STREET STREET 2: SUITE 1010 CITY: LEXINGTON STATE: MA ZIP: 02420 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 450 BEDFORD STREET STREET 2: SUITE 1010 CITY: LEXINGTON STATE: MA ZIP: 02420 DEF 14A 1 tm242845-4_def14a.htm DEF 14A tm242845-4_def14a - none - 4.8593835s TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 ​ Filed by the Registrant [X] ​ ​ Filed by a Party other than the Registrant [ ] ​ Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X] Definitive Proxy Statement [ ] Definitive Additional Materials [ ] Soliciting Material Pursuant to § 240.14a-12 iSpecimen Inc. (Name of Registrant as Specified in its Charter) N/A (Name of Person(s) Filing Proxy Statement, if other than the Registrant) PAYMENT OF FILING FEE (Check the appropriate box): [X] No fee required. ​ [ ] Fee paid previously with preliminary materials. ​ [ ] Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. ​ TABLE OF CONTENTS   iSpecimen Inc. 450 Bedford Street Lexington, MA 02420 June 10, 2024 Dear Fellow Stockholders: On behalf of the board of directors (“Board of Directors”) of iSpecimen Inc., I cordially invite you to attend the 2024 annual meeting of stockholders (the “Annual Meeting”) of iSpecimen Inc., which will be held virtually via the Internet, commencing at 10:00 a.m. Eastern Time on July 19, 2024). In order to attend the meeting, you must log on to www.virtualshareholdermeeting.com/ISPC2024 and enter the 16-digit control number on your proxy card or in the instructions that accompanied your proxy materials. The Annual Meeting will be held for the following purposes: 1. To elect two (2) Class III directors each to serve for a three-year term that expires at the 2027 Annual Meeting of Stockholders, or until the election and qualification of their respective successors in office, subject to their earlier death, resignation or removal; ​ 2. To approve an amendment to our Fourth Amended and Restated Certificate of Incorporation to effect a reverse stock split of our outstanding shares of common stock, par value $0.0001 per share, at a ratio, ranging from one-for-ten (1:10) to one-for-twenty (1:20), with the exact ratio to be set within that range at the discretion of our board of directors (“Board of Directors”) without further approval or authorization of our stockholders; ​ 3. To ratify the appointment of Wolf & Company, P.C. as our independent registered public accounting firm for the year ending December 31, 2024; and ​ 4. To transact such other business as may properly come before the Annual Meeting or any continuation, postponement or adjournment thereof. ​ To all stockholders of record at the close of business on June 3, 2024, attached to this letter are a Notice of Annual Meeting of Stockholders and the Proxy Statement, which describe the bu